CC 3052

Known as: CC-3052 
 

Topic mentions per year

Topic mentions per year

1998-2016
012319982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The lengthy duration of multidrug therapy needed to cure tuberculosis (TB) poses significant challenges for global control of the… (More)
Is this relevant?
2013
2013
PURPOSE To evaluate the effect of thalidomide analogue CC-3052 on corneal neovascularization in the rabbit model. METHODS… (More)
Is this relevant?
2011
2011
Tuberculosis (TB) treatment is hampered by the long duration of antibiotic therapy required to achieve cure. This indolent… (More)
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Tuberculosis (TB) is responsible for significant morbidity and mortality worldwide. Even after successful microbiological cure of… (More)
Is this relevant?
2011
2011
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the leading infectious disease causes of morbidity and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2000
2000
Thalidomide has significant immunomodulatory properties and has been used successfully in the treatment of oral ulcers and… (More)
Is this relevant?
2000
2000
We investigated the in vitro effect of the water-soluble, highly stable thalidomide analogue CC-3052 on HIV-1 expression and TNF… (More)
Is this relevant?
1998
1998
The immunomodulatory drug thalidomide has been shown to be clinically useful in a number of situations due to its ability to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?